Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.

Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) worth of ordinary shares from Pfizer. In March, the U.S. pharma major had sold about $3.

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6%

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.

(Reuters) -Haleon plans to increase its stake in its Chinese joint venture to 88% from 55%, the British consumer healthcare company said on Friday. It will pay 4.47 billion yuan ($637 million) to buy the stake from partners Tianjin Pharmaceutical Group (TPG) and Tianjin Pharmaceutical Da Ren Tang Group (DRTG),

Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.

Pfizer Inc. ($PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC ($GB:HLN). With this transaction,

Pfizer (NYSE:PFE) has reduced its ownership in the British consumer healthcare giant Haleon (NYSE:HLN) to 15% from 22.6% by selling £2.45B ($3.26B) worth of company shares, Reuters reported Tuesday, citing a bookrunner.

Haleon said Pfizer's stake was expected to fall to 15 per cent from 22.6 per cent. Haleon shares fell 0.25 per cent or 1.00p to 391.90p, having risen around 15 per cent in the las